Rymedi and Incora Health announce their strategic partnership aimed at improving women’s health.
The Incora Health Earring, designed to monitor women’s whole health through their unique menstrual cycles, will leverage Rymedi’s blockchain-enabled patient and population health data platform to serve as a comprehensive digital patient and results management tool. Rymedi’s patented technology separates PHI from PII, securely storing a permanent and auditable record of the collection and resulting process.
Lindsey Calcutt, PhD, the Co-Founder and CEO of Incora Health, expressed her enthusiasm for the partnership, saying, “We are thrilled to partner with Rymedi to leverage their cutting-edge blockchain technology. This collaboration will enhance our ability to provide secure, reliable, and innovative health monitoring solutions to women via the Incora earring and app, ensuring their data is protected and their health insights are precise.”
David Stefanich, CEO and Founder of Rymedi, expressed his enthusiasm by saying “this partnership continues our mission to help life science organizations improve human health. We are excited to bringWeb3 and DeSci solutions to the global diagnostic testing device market.”
